Help or hindrance? Rituximab maintenance and COVID Editorial
| Author: | Noy, A. |
| Title: | Help or hindrance? Rituximab maintenance and COVID |
| Keywords: | rituximab; progression free survival; mantle cell lymphoma; editorial; bendamustine; cyclophosphamide; intensive care unit; hospitalization; hematologic malignancy; antibody response; immunosuppressive treatment; follicular lymphoma; immunocompromised patient; seroconversion; chemoimmunotherapy; human; male; female; article; obinutuzumab; cyclophosphamide plus doxorubicin plus prednisolone plus rituximab plus vincristine; chimeric antigen receptor t-cell immunotherapy; coronavirus disease 2019; vaccine hesitancy |
| Journal Title: | Haematologica |
| Volume: | 110 |
| Issue: | 1 |
| ISSN: | 0390-6078 |
| Publisher: | Ferrata Storti Foundation |
| Date Published: | 2025-01-01 |
| Start Page: | 18 |
| End Page: | 19 |
| Language: | English |
| DOI: | 10.3324/haematol.2024.286142 |
| PUBMED: | 39279441 |
| PROVIDER: | scopus |
| PMCID: | PMC11694106 |
| DOI/URL: | |
| Notes: | Editorial -- Source: Scopus |
